IR1200, IR1250(IR1200 Plus), 2020 and One Touch(R) Ping(R) Insulin Pump glucose management system. The device is intended to deliver insulin therapy.
Published October 10, 2012 · Recall initiated: July 16, 2012
Summary
FDA records medical device Class II recall Z-0005-2013, published October 10, 2012 and initiated July 16, 2012. Recalling firm: Animas Corporation; Status: Terminated; Reported quantity: 236,470; Lot: OneTouch(R) Ping(TM) Glucose Management Systems - Part Numbers 101420-00, 101421-00, 101422-00, 101424-00, 101425-00, 100430-00, 100431-00, 100432-00, 100434-00, 100435-00, 101420-98, 101421-98, 101422-98, 101424-98, and 101425-98; Animas(R) 2020 Insulin Infusion Pumps - Part numbers 101370-00, 101371-00, 101372-00, 101374-00, 101375-00, 100380-00, 100381-00, 100382-00, 100384-00, and 100385-00; Animas(R) IR 1250 (1200 Plus) Insulin Infusion Pumps -- Part numbers 100250-00, 100251-00, and 100252-00; and Animas(R) IR 1200 Insulin Infusion Pumps - Part numbers 100200-00, 100201-00, and 100202-00. Serial numbers -- will be provided. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Wear of the keypad that may lead to damage such as tearing or peeling of the edge of the keypad from the pump.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Animas Corporation
- Distributor
- Worldwide distribution: USA (nationwide) including states of: AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, V, VT, WA, WI, WV, WY and Washington, DC and countries of: Austria, Australia, Canada, Czech Republic, France, Finland, Germany, Hungary, Israel, Italy, Mexico, New Zealand, Puerto Rico, Spain, and United Kingdom.
- Lot
- OneTouch(R) Ping(TM) Glucose Management Systems - Part Numbers 101420-00, 101421-00, 101422-00, 101424-00, 101425-00, 100430-00, 100431-00, 100432-00, 100434-00, 100435-00, 101420-98, 101421-98, 101422-98, 101424-98, and 101425-98; Animas(R) 2020 Insulin Infusion Pumps - Part numbers 101370-00, 101371-00, 101372-00, 101374-00, 101375-00, 100380-00, 100381-00, 100382-00, 100384-00, and 100385-00; Animas(R) IR 1250 (1200 Plus) Insulin Infusion Pumps -- Part numbers 100250-00, 100251-00, and 100252-00; and Animas(R) IR 1200 Insulin Infusion Pumps - Part numbers 100200-00, 100201-00, and 100202-00. Serial numbers -- will be provided.
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAAnimas Vibe Insulin Infusion Pump and System. These products are indicated for continuous subcutaneousNovember 5, 2014
- FDAAnimas Vibe Insulin Infusion Pump. This product is indicated for continuous subcutaneous infusion of insulinNovember 5, 2014
- FDAAnimas(R) 2020 Insulin Infusion Pump Product Usage: This product is indicated for continuous subcutaneousApril 10, 2013
- FDAAnimas(R) 2020, Animas(R) IR 1250 (1200 plus), Animas(R) IR 1200 Insulin Infusion Pumps Indicated forFebruary 27, 2013
- FDAMale, 16Fr, Straight-tip Intermittent Urinary Catheters M16. The product is distributed individually or inOctober 10, 2012
- FDAEndoscopic retrieval device. The disposable Raptor grasping device in intended to retrieve foreign bodies orOctober 10, 2012
Questions about this recall
Was IR1200, IR1250(IR1200 Plus), 2020 and One Touch(R) Ping(R) Insulin Pump glucose management system. The device is intended to deliver insulin therapy. recalled?
Yes. FDA published recall Z-0005-2013 on October 10, 2012. Reported hazard: Wear of the keypad that may lead to damage such as tearing or peeling of the edge of the keypad from the pump.
What should I do if I have this product?
Voluntary: Firm initiated · Letter